tRNA-Enhanced Lipofection for Mammalian Gene Transfer
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene transfer methods to mammalian cells, such as the lipofection method, face inefficiencies compared to virus vector methods, and existing methods do not effectively utilize tRNA for enhancing gene transfer efficiency.
Innovation Solution
Combining tRNA with a lipofection reagent, specifically using yeast-derived, calf liver-derived, wheat germ-derived, or E. coli-derived tRNA, at concentrations ranging from 3 to 50 µg/mL, along with polyethylene glycol of molecular weights between 2,000 to 6,000, to improve gene transfer efficiency in mammalian cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If the lipofection method is used for gene transfer to mammalian cells, then the method is simple and versatile, but the gene transfer efficiency is inferior to virus vector methods
Solution Approach 1:
The patent changes the chemical parameters of the lipofection system by introducing tRNA as a co-transfectant agent. This parameter change transforms the lipofection method from a simple but inefficient process to an enhanced system that achieves virus-vector-like efficiency while maintaining operational simplicity. The tRNA component modifies the interaction between liposome and DNA, improving uptake efficiency without complicating the basic procedure.
Solution Approach 2:
The patent creates a composite transfection system combining lipofection reagents with tRNA. This composite approach merges the simplicity of lipofection with the high efficiency of virus vector methods. The tRNA acts as an auxiliary agent that enhances the liposome-DNA complex interaction, creating a synergistic effect that achieves both ease of operation and high productivity.
2Productivity
If virus vector methods are used for gene transfer, then gene transfer efficiency is high, but the process is time-consuming and requires specialized facilities and personnel
Solution Approach 1:
The patent extracts the essential function of virus vectors (high efficiency gene transfer) while removing the time-consuming and complex components (virus production, specialized facilities, skilled personnel). By using tRNA-enhanced lipofection, the method achieves virus-like efficiency without requiring virus cultivation time or specialized containment facilities, thus separating the beneficial outcome from the cumbersome process.
Solution Approach 2:
The patent replaces complex, time-consuming virus vector systems with a simpler, faster lipofection-based system using tRNA. This approach uses readily available reagents and cells, eliminating the need for expensive virus production infrastructure and specialized personnel, while achieving comparable or superior gene transfer efficiency in a fraction of the time.
3Productivity
If tRNA is added to lipofection solution, then gene transfer efficiency is significantly improved, but the complexity of the procedure increases
Solution Approach 1:
The patent merges tRNA with the lipofection reagent in a single combined solution, treating the enhancement agent as an integral part of the transfection system. This merging approach simplifies the procedure by eliminating separate addition steps and ensuring proper mixing, while maintaining the efficiency boost. The tRNA is incorporated into the liposome-DNA complex formation process itself, rather than being added as a separate subsequent step.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This combination significantly enhances gene transfer efficiency, as demonstrated by up to 58-fold increases in luciferase activity assays, indicating effective gene incorporation into mammalian cells.
Implementation Method 1
The lipofection method is a method which involves forming a liposome-DNA complex by the electric interaction between a lipid bilayer membrane vesicle consisting of a positively charged lipid or the like (liposome) and DNA to be transferred and incorporating the complex into host cells by phagocytosis or membrane fusion.
Implementation Method 2
forming a liposome-DNA complex by the electric interaction between a lipid bilayer membrane vesicle consisting of a positively charged lipid or the like (liposome) and DNA to be transferred
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Provided is an efficiency improving agent for gene transfer to mammalian cells, a method for improving efficiency of gene transfer to mammalian cells, and a method for transforming mammalian cells. The method is characterized in that tRNA is used in combination with a lipofection reagent. Preferably, the agent may be used so that the tRNA concentration in a lipofection solution falls within the range of 3 to 50 µg/mL, and the concentration in a culture is approximately 1/10. More preferably, tRNA and PEG may be used in combination with a lipofection reagent. According to the present invention, gene transfer to mammalian cells with high efficiency can be achieved.